Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

Exclusion Criteria

• •Presence of extensive skin changes/diseases at sensor wear site(s) that preclude wearing the sensor(s) on skin
• •Known allergy to medical-grade adhesives
• •Pregnancy
• •Hematocrit outside specification
• •≥ 18 years of age:
• •* Male: 36.0%;
• •* Female: 33.0%;
• •13-17 years of age: 35.0%;
• •7 years - 12 years of age: 32.0%;
• •End stage renal disease and currently managed by dialysis or anticipating initiating dialysis during the study wear period
• •Required or scheduled to have a Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, or diathermy during the study wear period